Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

Summary

The goal of this clinical research study is to learn if dasatinib can help to control Chronic Lymphocytic Leukemia (CLL). The safety of the drug will also be studied. Optional Procedures: You will be asked to have additional blood samples drawn. These samples will be used to see how the disease is responding to the drug.

Timeline

Start

2006-08

Primary completion

2012-11

Completion

2012-11

Drugs

Indications